Professional Documents
Culture Documents
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide
range of content in a trusted digital archive. We use information technology and tools to increase productivity and
facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at
https://about.jstor.org/terms
This content downloaded from 14.139.228.235 on Fri, 12 Feb 2021 08:23:24 UTC
All use subject to https://about.jstor.org/terms
IN DEPTH
Scientists,
Scientists,physicians,
physicians,
ethicists.
ethicists.and
andothers
othersdebated
debated
human
human gene
geneediting
editingatat
the
the
Washington,
Washington,D.C.,
D.C.,summit.
summit.
GENETIC ENGINEERING
Germline
Germlineediting
editingdominates
dominates
DNADNA
summit
summit
Prospect of heritable changes sparks questions about safety, ethics, and rationa
By
/JohnTravis John Travis cations could be justified to prevent the the U.S. National Academy of Medicine,
inheritance of disease or, more contro the United Kingdom's Royal Society, and
versially, to produce "enhancements" suchthe Chinese Academy of Sciences rushed to
shadow of eugenics. Philosophi as higher IQ or a reduced need for sleep. In convene the summit.
cal, ethical, and moral debates. fact, the organizers called for an "ongoing By tweaking CRISPR's RNA or nuclease
Uncertain science and patchy regu international forum" to regularly revisit the components, researchers expect to make
» congressman's warning. The long issue of germline editing. "The unthinkable the tool, developed from an immune sys
lations. And a cast that included
scientists expected to share ahas become conceivable," declared biologist tem found in bacteria, still more precise.
Nobel
Prize for a new DNA-changing technology, David Baltimore of the California Institute And "there are likely more powerful sys
commonly called CRISPR. All was on dis of Technology in Pasadena, the chairperson tems still out there in nature," noted Feng
play last week at the International Summit of the organizing committee. Zhang of the Broad Institute in Cambridge,
on Human Gene Editing, held at the U.S. The new molecular toolkit motivating the Massachusetts, who at one point shared the
National Academy of Sciences (NAS) in summit, CRISPR, consists of a DNA-cutting stage with other CRISPR pioneers, Jennifer
Washington, D.C. enzyme called a nuclease and a piece of RNA Doudna of University of California, Berke
"CRISPR and related technologies have ley, and Emmanuelle Charpentier of the
the potential to revolutionize the treat Max Planck Institute for Infection Biology
ment of diseases but could be used in in Berlin. Many predict the trio will win a
many ways not beneficial to society," "The noted
unthinkable Nobel for developing the system.
Representative Bill Foster (D-IL), has the become
only conceivable Few at the summit had qualms about us
Ph.D. physicist in the U.S. Congress, as the ing CRISPR and its rivals in somatic cells to
David Baltimore. California Institute
summit opened. treat disease. By applying zinc finger nucle
of Technology
The gathering ended on a similar note: ases to immune cells in vitro, groups have
The organizing committee strongly en already deactivated the gene for CCR5, a pro
dorsed the use of CRISPR and similar meth that homes in on a DNA sequence, en tein that the AIDS virus uses to invade the
abling researchers to create precisely tar cells; the modified cells were then returned
z ods for basic research that involves altering
§ DNA of human sperm, eggs, and embryos, geted mutations, corrections to mutations, to HIV-infected people. And last month, a
I but concluded that producing a pregnancy or other alterations. Along with two earlier team reported on using TALENs to edit can
s from such modified cells or embryos genome is cur editors, zinc finger nucleases andcer-fighting immune cells that subsequently
I rently "irresponsible" because of ongoing TALENs, CRISPR is transforming basic arrested leukemia in a 1-year-old girl. Speak
£ safety concerns and a lack of societal con biology and aiding the development of newers also discussed plans to use CRISPR on
£ sensus. Yet the group—12 biologists, physi crops and farm animals. Earlier this year, blood
a stem cells to reverse disorders such as
S cians, and bioethicists—did not flatly rule Chinese team became the first to publicly sickle cell anemia and beta thalassemia by
< out future use of such "germline editing," report using CRISPR to alter the DNA of fixing hemoglobin gene mutations.
| in which the DNA changes would be passed human embryos—nonviable ones—from in Biologist Janet Rossant of The Hospi
| down from one generation to the next, vitro fertilization (IVF) clinics, and a U.K. tal for Sick Children in Toronto, Canada,
O
g Much of the summit's discussions re group said it wanted to do similar research among others, spoke of the need to go fur
PHOT:NATIONAL CADEMYOFSCIEN S/PJ
AMRISDON volved around whether germline modifi in the United Kingdom. In response, NAS, ther and use gene editing to do basic re
This content downloaded from 14.139.228.235 on Fri, 12 Feb 2021 08:23:24 UTC
All use subject to https://about.jstor.org/terms
NEWS I IN DEPTH
This content downloaded from 14.139.228.235 on Fri, 12 Feb 2021 08:23:24 UTC
All use subject to https://about.jstor.org/terms